Humana’s stock was headed for another sharp selloff on Tuesday, toward a more than four-year low, after the government cut ...

周四，尽管面临美国医疗保险和医疗补助服务中心（CMS）对其计划评级的挑战，Raymond James仍维持Humana Inc.（NYSE:HUM）股票的"市场表现"评级。该公司股价在初始下跌后略有回升，交易价格为247美元，较近期高点大幅下跌。

周四，Piper Sandler调整了对Humana Inc. (NYSE:HUM)的立场，将该股票从"增持"下调至"中性"。该公司还将目标价从之前的392美元下调至274美元。这一决定是在Humana发布8K表格后做出的，该表格显示，公司仅有25%的Medicare Advantage (MA)和Special Needs Plans (SNP)会员参与了2025年4.0星级以上的计划。这与20 ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer ...

Tesla extends losses following the release of third-quarter deliveries, and Levi Strauss tumbles after cutting its ...

Shares slid more than 20% as the health insurer prepares for a one-star cut to its largest plan, which contains about 45% of ...

Shares of Humana have tumbled after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus ...

The recent developments have cratered Humana stock price, and it is now trading under our earlier targets. Read why we remain ...

Humana Inc. shares plummeted the most in 15 years after the insurer suffered a drop in Medicare Advantage quality ratings, ...

Humana (HUM) stock faces a 15% premarket dip as it discloses a significant decline in mmbers enrolled in highly rated ...

Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...